These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32140650)

  • 1. Limited efficacy of zonisamide in the treatment of refractory infantile spasms.
    Hussain SA; Navarro M; Heesch J; Ji M; Asilnejad B; Peters H; Rajaraman RR; Sankar R
    Epilepsia Open; 2020 Mar; 5(1):121-126. PubMed ID: 32140650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Felbamate in the treatment of refractory epileptic spasms.
    Hussain SA; Asilnejad B; Heesch J; Navarro M; Ji M; Shrey DW; Rajaraman RR; Sankar R
    Epilepsy Res; 2020 Mar; 161():106284. PubMed ID: 32058261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of infantile spasms relapse: Zonisamide and topiramate provide no benefit.
    Rajaraman RR; Lay J; Alayari A; Anderson K; Sankar R; Hussain SA
    Epilepsia; 2016 Aug; 57(8):1280-7. PubMed ID: 27312124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, tolerability, and safety of zonisamide in children with epileptic spasms: A systematic review and meta-analysis.
    Panda PK; Sharawat IK; Panda P; Dawman L
    Seizure; 2021 Oct; 91():374-383. PubMed ID: 34298456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zonisamide in West syndrome: an open label study.
    Yum MS; Ko TS
    Epileptic Disord; 2009 Dec; 11(4):339-44. PubMed ID: 20045779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Very-High-Dose Prednisolone Before ACTH for Treatment of Infantile Spasms: Evaluation of a Standardized Protocol.
    Eliyan Y; Heesch J; Alayari A; Rajaraman RR; Sankar R; Hussain SA
    Pediatr Neurol; 2019 Oct; 99():16-22. PubMed ID: 31331669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience.
    Schwarz MD; Li M; Tsao J; Zhou R; Wu YW; Sankar R; Wu JY; Hussain SA
    Epilepsy Behav; 2016 Apr; 57(Pt A):29-33. PubMed ID: 26921595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of infantile spasms with zonisamide.
    Yanai S; Hanai T; Narazaki O
    Brain Dev; 1999 Apr; 21(3):157-61. PubMed ID: 10372900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited efficacy of the ketogenic diet in the treatment of highly refractory epileptic spasms.
    Hussain SA; Shin JH; Shih EJ; Murata KK; Sewak S; Kezele ME; Sankar R; Matsumoto JH
    Seizure; 2016 Feb; 35():59-64. PubMed ID: 26803052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of vigabatrin in Japanese patients with infantile spasms: Primary short-term study and extension study.
    Ohtsuka Y
    Epilepsy Behav; 2018 Jan; 78():134-141. PubMed ID: 29190579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving Outcomes in Infantile Spasms: Role of Pharmacotherapy.
    Iyer A; Appleton R
    Paediatr Drugs; 2016 Oct; 18(5):357-66. PubMed ID: 27541933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of infantile spasms.
    Hancock EC; Osborne JP; Edwards SW
    Cochrane Database Syst Rev; 2008 Oct; (4):CD001770. PubMed ID: 18843624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial.
    O'Callaghan FJK; Edwards SW; Alber FD; Cortina Borja M; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay MT; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
    Lancet Child Adolesc Health; 2018 Oct; 2(10):715-725. PubMed ID: 30236380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and electroclinical evolution in 22 cases with epileptic spasms without hypsarrhythmia.
    Koichihara R; Hamano SI; Daida A; Nonoyama H; Ikemoto S; Hirata Y; Matsuura R
    Epileptic Disord; 2020 Feb; 22(1):73-82. PubMed ID: 32020895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A risk-benefit assessment of treatments for infantile spasms.
    Nabbout R
    Drug Saf; 2001; 24(11):813-28. PubMed ID: 11665869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of vigabatrin-associated brain abnormalities on MRI in the treatment of infantile spasms is dose-dependent.
    Hussain SA; Tsao J; Li M; Schwarz MD; Zhou R; Wu JY; Salamon N; Sankar R
    Epilepsia; 2017 Apr; 58(4):674-682. PubMed ID: 28230253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, tolerability, and effectiveness of oral zonisamide therapy in comparison with intramuscular adrenocorticotropic hormone therapy in infants with West syndrome.
    Angappan D; Sahu JK; Malhi P; Singhi P
    Eur J Paediatr Neurol; 2019 Jan; 23(1):136-142. PubMed ID: 30293931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Modified Atkins Diet for the Treatment of Epileptic Spasms Refractory to Hormonal Therapy: A Randomized Controlled Trial.
    Sharma S; Goel S; Kapoor D; Garg D; Panda I; Elwadhi A; Patra B; Mukherjee SB; Pemde H
    J Child Neurol; 2021 Jul; 36(8):686-691. PubMed ID: 33834913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial.
    O'Callaghan FJ; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
    Lancet Neurol; 2017 Jan; 16(1):33-42. PubMed ID: 27838190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infantile spasms syndrome, West syndrome and related phenotypes: what we know in 2013.
    Pavone P; Striano P; Falsaperla R; Pavone L; Ruggieri M
    Brain Dev; 2014 Oct; 36(9):739-51. PubMed ID: 24268986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.